title: Assessing the lipophilicity of fragments and early hits.
abstract: A key challenge in many drug discovery programs is to accurately assess the potential value of screening hits. This is particularly true in fragment-based drug design (FBDD), where the hits often bind relatively weakly, but are correspondingly small. Ligand efficiency (LE) considers both the potency and the size of the molecule, and enables us to estimate whether or not an initial hit is likely to be optimisable to a potent, druglike lead. While size is a key property that needs to be controlled in a small molecule drug, there are a number of additional properties that should also be considered. Lipophilicity is amongst the most important of these additional properties, and here we present a new efficiency index (LLE(AT)) that combines lipophilicity, size and potency. The index is intuitively defined, and has been designed to have the same target value and dynamic range as LE, making it easily interpretable by medicinal chemists. Monitoring both LE and LLE(AT) should help both in the selection of more promising fragment hits, and controlling molecular weight and lipophilicity during optimisation.
authors: Astex Therapeutics, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA, England, UK. p.mortenson@astex-therapeutics.com
authors: Paul N
authors: PN
authors: Mortenson
authors: Christopher W
authors: CW
authors: Murray
references: Nat Rev Drug Discov. 2009 Mar;8(3):203-12
references: 19247303
references: J Med Chem. 2008 Apr 24;51(8):2432-8
references: 18380424
references: Bioorg Med Chem Lett. 2009 Aug 1;19(15):4406-9
references: 19500981
references: J Mol Graph Model. 2003 Sep;22(1):71-82
references: 12798392
references: J Med Chem. 2006 Nov 30;49(24):6972-6
references: 17125250
references: Drug Discov Today. 2005 Apr 1;10(7):464-9
references: 15809192
references: Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):9997-10002
references: 10468550
references: Drug Discov Today. 2005 Jul 15;10(14):987-92
references: 16023057
references: Drug Discov Today. 2004 May 15;9(10):430-1
references: 15109945
references: J Med Chem. 2003 Mar 27;46(7):1250-6
references: 12646035
references: J Med Chem. 2001 Apr 26;44(9):1313-33
references: 11311053
references: J Chem Inf Model. 2009 Jun;49(6):1617-22
references: 19438171
references: ChemMedChem. 2008 Aug;3(8):1179-80
references: 18651625
references: Nat Rev Drug Discov. 2007 Nov;6(11):881-90
references: 17971784
references: Bioorg Med Chem Lett. 2007 Aug 1;17(15):4258-61
references: 17532632